BusinessKaryopharm Presents Updated Phase 2b STORM Data at the American Society of Hematology 2016 Annual MeetingBy Nasdaq OMXDec 5, 2016, 12:30 AM UTC
BusinessKaryopharm Presents Updated Phase 2 SAIL Relapsed/Refractory AML Clinical Data at the American Society of Hematology 2016 Annual MeetingBy Nasdaq OMXDec 4, 2016, 5:30 PM UTC
BusinessCytokinetics Announces Presentations at the International Symposium on ALS/MNDBy Nasdaq OMXDec 2, 2016, 9:00 PM UTC
BusinessTonix Pharmaceuticals to Present Clinical Data at the 55th Annual Meeting of the American College of Neuropsychopharmacology (ACNP)By Nasdaq OMXDec 2, 2016, 12:21 PM UTC
BusinessProtalix BioTherapeutics Announces Private Note Exchanges and Private Placement of Secured Convertible Notes due 2021By Nasdaq OMXDec 1, 2016, 9:44 PM UTC
BusinessCellectar Biosciences Announces Results From the First Two Cohorts of Its CLR 131 Phase 1 Trial: Demonstrates Excellent Efficacy, Overall Survival Benefit, and Progression Free Survival Similar to or Better than Recently Approved TherapiesBy Nasdaq OMXDec 1, 2016, 1:00 PM UTC
BusinessCytokinetics Announces Start of GALACTIC-HF, a Phase 3 Clinical Trial of Omecamtiv MecarbilBy Nasdaq OMXDec 1, 2016, 12:30 PM UTC
